Others Urological ConditionsArchives
Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological features
Others Urological Conditions 7 min.
Colorectal cancer (CRC) ranks as the second leading cause of cancer-related deaths worldwide [1]. The treatment protocols and prognosis of CRC are influenced by various factors, such as the Tumor-Node-Metastasis classification, mismatch-repair (MMR) status, and tumor morphology [2, 3–4]. Around...
Application of PBL combined with mini-CEX evaluation model in the clinical teaching of urological clinic teaching
Others Urological Conditions 4 min.
As breakthroughs in medicine and science accelerate global economic growth, medical education is becoming ever more interconnected and globally oriented [1]. Clinical internship constitutes the pivotal step of medical training, during which medical students successfully translate textbook knowledge into...
Characterization and genome analysis of jumbo Escherichia phage UE-S1 and the antibacterial potential of its lysozyme against uropathogenic E. coli
Others Urological Conditions 9 min.
E. coli is an opportunistic pathogen that naturally inhabits the gastrointestinal tract, where it generally exists as part of the normal microbiota without causing harm [1]. However, under certain conditions, it can lead to a variety of intestinal and extraintestinal infections, the most common...
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
Others Urological Conditions 1 min.
In recent years, several clinical trials focused on the potential role of immune-checkpoint inhibitors (ICIs) in the adjuvant treatment of muscle-invasive urothelial cancer (UC). Heretofore, only the anti-programmed death protein 1 (anti-PD1) nivolumab received European Medical Agency (EMA) approval...
